Canna-V-Cell Sciences (CSE:CNVC) has launched its campaign on the Investing News Network’s cannabis channel.

Canna-V-Cell is a cannabis technology company that is the exclusive international licensee for the patent-protected BioHarvest system, a large-scale plant growth technology that is capable of producing active plant ingredients without having to physically grow the plant itself. The company intends to adapt the BioHarvest technology in order to create the active ingredients found in cannabis. Canna-V-Cell intends to leverage its technology to enter the medical and recreational cannabis space.


Canna-V-Cell’s biofarming techniques are designed to solve the supply and consistency problems that are currently hindering the cannabis industry. To achieve the company’s biofarming goals, Canna-V-Cell has designed a production facility capable of creating approximately one ton of powder containing active cannabis ingredients. The company is currently testing the feasibility of its process but expects to release products by 2020.

Canna-V-Cell’s company highlights include the following:

  • Over 10 years and $30 million have been invested in developing the Biofarming technology.
  • The Biofarming technology is expected to ease bottlenecks in the cannabis industry.
  • Canna-V-Cell will be utilizing a B2B business model and will supply its active ingredient products as a powder for repackaging by its clients.
  • The company is expecting to launch its products by 2020.
  • The current production capacity of the company’s facility is 2 tons per year and is expected to increase to 10 tons per year.
  • Canna-V-Cell’s seasoned management team has a track record of success behind them.
  • Bioharvest (the inventor and licensor of Biofarming) notably holds 50 percent of shares.

Click here to connect with Canna-V-Cell Sciences (CSE:CNVC) to request an investor presentation.

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less

 Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.

For more information regarding the Company or the offering, please contact ir@hillstreetbevco.com, or

Keep reading... Show less